Browse diseases

…(CNS) and peripheral nervous system (PNS)—based on the 1999 ACR NPSLE case definitions and current literature. Statistical analyses w…

…vel at 12 hours of 4-6 ug/L.Results Before TAC, the duration of lupus nephritis (LN) was 46 (in the range of 12-162) months. The drug therapy p…

…ental health support, inter-speciality fragmented care, and low lupus awareness among non-specialists. The findings provided a clear …

… allowing patients to achieve meaningful clinical responses off SLE therapies. Both cohorts are fully enrolled, with additional pos…

…Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease causing multi-organ damag…

…y provides novel insights into systemic metabolic remodeling in lupus nephritis and identifies dapagliflozin-associated shifts in amino acid an…

…roportion of moderate (74.3% vs 66.9%) or severe (3.7% vs 2.2%) SLE, but similar baseline organ damage ( table 1). Baseline moderat…

…ing that steroid-free remission is a realistic clinical goal in SLE management. Steroid-free management of more inflammatory manife…

…d, multicenter, retrospective cohort study based on the Chinese SLE Treatment and Research Registry (CSTAR). Maintenance therapy wa…

…ersus placebo (1:1) across 21 North American sites. Ninety-four JSLE patients (mean [SD] age 15.3 [2.4] years; 78% female) with matc…

…o identify clinical and socio-demographic correlates of PASS in systemic lupus erythematosus (SLE).Methods We analyzed data from the large multicenter RELES…

… of patients receiving PBO+SOC had moderate and moderate/severe BILAG-2004 flares using the alternative definitions; lower proportions of …